Elena Poletto

848 total citations
34 papers, 585 citations indexed

About

Elena Poletto is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elena Poletto has authored 34 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elena Poletto's work include HER2/EGFR in Cancer Research (8 papers), Cancer Genomics and Diagnostics (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). Elena Poletto is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Cancer Genomics and Diagnostics (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). Elena Poletto collaborates with scholars based in Italy, United States and Portugal. Elena Poletto's co-authors include Fabio Puglisi, Alessandro Marco Minisini, Gianpiero Fasola, Lorenzo Gerratana, Manuela Giangreco, Marta Bonotto, Claudia Andreetta, Mauro Mansutti, Stefania Russo and Federica Pisa and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Elena Poletto

34 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Poletto Italy	14	398	189	183	168	46	34	585
Giacomo Pelizzari Italy	15	394 1.0×	158 0.8×	271 1.5×	146 0.9×	50 1.1×	50	623
Parvin F. Peddi United States	14	404 1.0×	152 0.8×	200 1.1×	206 1.2×	53 1.2×	30	661
Evangelos Bournakis Greece	15	267 0.7×	153 0.8×	160 0.9×	272 1.6×	39 0.8×	35	621
Dan Chan United States	6	287 0.7×	84 0.4×	194 1.1×	250 1.5×	43 0.9×	13	532
Caterina Fontanella Italy	13	375 0.9×	139 0.7×	196 1.1×	145 0.9×	28 0.6×	43	625
Arpita Desai United States	10	165 0.4×	116 0.6×	185 1.0×	229 1.4×	31 0.7×	38	451
Eleni Zografos Greece	13	233 0.6×	160 0.8×	112 0.6×	183 1.1×	29 0.6×	43	497
Simona Duranti Italy	12	236 0.6×	102 0.5×	149 0.8×	114 0.7×	22 0.5×	28	449
Rossella Martinello Italy	13	431 1.1×	229 1.2×	210 1.1×	134 0.8×	22 0.5×	26	626
Mariangela Zanghì Italy	7	234 0.6×	79 0.4×	211 1.2×	144 0.9×	19 0.4×	12	414

Countries citing papers authored by Elena Poletto

Since Specialization

Citations

This map shows the geographic impact of Elena Poletto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Poletto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Poletto more than expected).

Fields of papers citing papers by Elena Poletto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Poletto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Poletto. The network helps show where Elena Poletto may publish in the future.

Co-authorship network of co-authors of Elena Poletto

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Poletto. A scholar is included among the top collaborators of Elena Poletto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Poletto. Elena Poletto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arcieri, Martina, Claudia Andreetta, Stefano Restaino, et al.. (2024). How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature. Frontiers in Oncology. 14. 1335196–1335196. 15 indexed citations

Targato, Giada, Elisa Bertoli, Claudia Andreetta, et al.. (2022). Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?. Frontiers in Oncology. 12. 885992–885992. 3 indexed citations

Basile, Debora, Giada Targato, Marco Alberti, et al.. (2021). 295P Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi). Annals of Oncology. 32. S493–S493. 3 indexed citations

Picelli, Alessandro, Elena Poletto, Valentina Varalta, et al.. (2021). May ultrasonography be considered a useful tool for bedside screening of dysphagia in patients with acute stroke? A cohort study. Minerva Medica. 112(3). 354–358. 9 indexed citations

Garziera, Marica, Rossana Roncato, Marcella Montico, et al.. (2019). New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach. Cells. 8(6). 584–584. 27 indexed citations

Garziera, Marica, Erika Cecchin, Giorgio Giorda, et al.. (2019). Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC). Cells. 8(10). 1186–1186. 8 indexed citations

Gagno, Sara, Elena Poletto, Michele Bartoletti, et al.. (2019). A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer. Gynecologic Oncology. 156(1). 233–242. 4 indexed citations

Bertoli, Elisa, Giada Targato, Maria Grazia Vitale, et al.. (2019). Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?. Annals of Oncology. 30. v78–v78. 1 indexed citations

Garziera, Marica, Erika Cecchin, Vincenzo Canzonieri, et al.. (2018). Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS). International Journal of Molecular Sciences. 19(5). 1510–1510. 14 indexed citations

10.

Bonotto, Marta, Lorenzo Gerratana, Giacomo Pelizzari, et al.. (2018). Association of clinical factors and biological subtypes with different Ca15-3 levels in metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e24014–e24014. 1 indexed citations

11.

Iacono, Donatella, Debora Basile, Lorenzo Gerratana, et al.. (2017). Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma. Annals of Oncology. 28. vi68–vi68. 4 indexed citations

12.

Lambertini, Matteo, Arlindo R. Ferreira, Antonio Di Meglio, et al.. (2017). Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study. Clinical Breast Cancer. 17(8). 601–610.e2. 25 indexed citations

13.

Martel, Samuel, Elena Poletto, Arlindo R. Ferreira, et al.. (2017). Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer. The Breast. 37. 142–147. 27 indexed citations

14.

Lambertini, Matteo, Arlindo R. Ferreira, Francesca Poggio, et al.. (2015). Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study. The Oncologist. 20(8). 880–889. 22 indexed citations

15.

Bonotto, Marta, Lorenzo Gerratana, Elena Poletto, et al.. (2014). Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario. The Oncologist. 19(6). 608–615. 220 indexed citations

16.

Foltran, Luisa, Giuseppe Aprile, Federica Pisa, et al.. (2014). Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study. Supportive Care in Cancer. 22(9). 2527–2533. 14 indexed citations

17.

Minisini, Alessandro Marco, Elena Poletto, Riccardo Spizzo, et al.. (2013). Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma. Melanoma Research. 23(2). 96–101. 13 indexed citations

18.

Minisini, Alessandro Marco, Lorenzo Gerratana, Manuela Giangreco, et al.. (2013). Risk factors and survival outcomes in patients with brain metastases from breast cancer. Clinical & Experimental Metastasis. 30(8). 951–956. 32 indexed citations

19.

Poletto, Mattia, Carla Di Loreto, Daniela Marasco, et al.. (2012). Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers. Biochemical and Biophysical Research Communications. 424(1). 34–39. 31 indexed citations

20.

Bonotto, Marta, et al.. (2012). Making Capecitabine Targeted Therapy for Breast Cancer: Which is the Role of Thymidine Phosphorylase?. Clinical Breast Cancer. 13(3). 167–172. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact